// App-Quantinova.ai

775 : Longitudinal investigation of PD-L1 expression on circulating tumor cells (CTCs) in non-small cell lung cancer (NSCLC) patients treated with nivolumab

Researchers

Presenter

  • Yasuhiro Koh

Principal Investigators

  • Mio Ikeda

  • Shunsuke Teraoka

  • Koichi Sato

  • Nahomi Tokudome

  • Atsushi Hayata

  • Hiroaki Akamatsu

  • Yuichi Ozawa

  • Keiichiro Akamatsu

  • Katsuya Endo

  • Masayuki Higuchi

  • Masanori Nakanishi

  • Hiroki Ueda

  • Nobuyuki Yamamoto

Medical Centers

  • Wakayama Medical University, Wakayama, Japan

  • Hitachi Chemical Co., Ltd, Chikusei, Japan

Locations

  • Japan

Companies

  • Hitachi Chemical Co.

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • Circulating tumor cells

  • Programmed death-ligand 1

Drug/Treatment

  • Nivolumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved